Evidence map›Paper›PMID 35818073›Full record

ArticleMicrobial cell factories2022

Enhancing very long chain fatty acids production in Yarrowia lipolytica.

Peter Gajdoš, Veronika Urbaníková, Mária Vicenová, Milan Čertík

Abstract read
In one paragraph

Article in Microbial cell factories, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peter GajdošInstitute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 81237, Bratislava, Slovak Republic. peter_gajdos@stuba.sk.
Veronika UrbaníkováInstitute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 81237, Bratislava, Slovak Republic.
Mária VicenováInstitute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 81237, Bratislava, Slovak Republic.
Milan ČertíkInstitute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 81237, Bratislava, Slovak Republic.

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-17-0262
6 · The paper itself

Abstract

backgroundVery long chain fatty acids (VLCFA) and their derivatives are industrially attractive compounds. The most important are behenic acid (C22:0) and erucic acid (C22:1Δ

resultsThe metabolism of Y. lipolytica was redesigned to achieve increased production of VLCFA. The effect of native diacylglycerol acyltransferases of this yeast YlLro1p, YlDga1p, and YlDga2p on the accumulation of VLCFA was examined. It was found that YlDga1p is the only enzyme with a beneficial effect. Further improvement of accumulation was achieved by overexpression of 3-ketoacyl-CoA synthase (TaFAE1) under 8UAS-pTEF promoter and blockage fatty acid degradation pathway by deletion of YlMFE1. The best-producing strain YL53 (Δmfe, pTEF-YlDGA1, 8UAS-pTEF-TaFAE1) produced 120 µg of very long chain fatty acids per g of produced biomass, which accounted for 34% of total fatty acids in biomass.

conclusionsRecombinant strains of Y. lipolytica have proved to be good producers of VLCFA. Redesign of lipid metabolism pathways had a positive effect on the accumulation of C22:1Δ

Indexed as

YarrowiaBiofuelsBiomassDiacylglycerol O-AcyltransferaseFatty AcidsBiofuelsDiacylglycerol O-AcyltransferaseFatty AcidsBehenic acidDiacylglycerol acyltransferaseErucic acidYarrowia lipolytica

Identifiers

PMID35818073
PMCPMC9275168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.